# POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)

Study · id `cardio:ct-nct03508219` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03508219](<https://clinicaltrials.gov/study/NCT03508219>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03508219

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 130 participants.

## Technical summary

Registry record NCT03508219. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08-10 (actual); primary completion 2021-04-15 (actual). Results posted on 2025-09-15.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT03508219, source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)
- Started: 2018-08-10 (actual) (ClinicalTrials.gov record NCT03508219, source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)
- Primary completion: 2021-04-15 (actual) (ClinicalTrials.gov record NCT03508219, source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)
- Completion: 2021-04-15 (actual) (ClinicalTrials.gov record NCT03508219, source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)
- Results first posted: 2025-09-15 (ClinicalTrials.gov record NCT03508219, source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)
- Countries: France; Italy; Poland (ClinicalTrials.gov record NCT03508219, source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03508219-2025-09-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
- Acronym: POLBOS-LM
- Condition: Coronary Stenosis
- Intervention (Device): BiOSS LIM C
- Lead sponsor: ECRI bv
- Lead sponsor class: INDUSTRY
- Collaborator: Cardialysis BV
- Collaborator class: INDUSTRY
- Collaborator: Balton Sp.zo.o.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: ECRI bv (`cardio:org-ecri-bv`)
- Registry lists this organization as a collaborator: Cardialysis BV (`cardio:org-cardialysis-bv`)
- Registry lists this organization as a collaborator: Balton Sp.zo.o. (`cardio:org-balton-sp-zo-o`)

## Provenance

Content hash: 727a7992c3dae161bf56cd1abe115e5152326041c3b645594545179c1d1cd6df
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
